MCE 的所有产品仅用作科学研究，我们不为任何个人用途提供产品和服务。

FW1256

CAS No. : 117089-08-4

MCE 站：FW1256

产品活性：FW1256 是一种苯基类似物，也是一种缓释硫化氢 (H₂S) 供体。FW1256 抑制 NF-κB 活性，并可诱导细胞凋亡 (apoptosis)，具有有效的抗炎作用，并可用于癌症和心血管疾病的研究。

研究领域：NF-κB  |  Apoptosis

作用靶点：NF-κB  |  Apoptosis

In Vitro: FW1256 (200 ?M; 24.5 hours; AW264.7 cells) treatment significantly reduces IL-1β, COX-2 and iNOS mRNA and protein in LPS-stimulated RAW264.7 macrophages.
FW1256 (200 ?M; 24.5 hours; AW264.7 cells) treatment significantly reduces IL-1β, COX-2 and iNOS PROTE and protein in LPS-stimulated RAW264.7 macrophages.
FW1256 concentration dependently decreases TNF-α (IC₅₀ of 61.2 ?M), IL-6 (IC₅₀ of 11.7 ?M), PGE2 (IC₅₀ of 25.5 ?M) and NO (IC₅₀ of 34.6 ?M) generation in LPS-stimulated RAW264.7 macrophages and bone marrow-derived macrophages (BMDMs) (IC₅₀s of 414.9 ?M, 300.2 ?M, 4 ?M and 9.5 ?M for TNF-α, IL-6, PGE2 and NO, respectively) .
FW1256 decreases NF-κB activation as evidenced by reduced cytosolic phospho-IκBα levels and reduces nuclear p65 levels in LPS-stimulated RAW264.7 macrophages treated with FW1256.

In Vivo: FW1256 (100 mg/kg; intraperitoneal injection; male C57BL/6 mice) treatment reduces IL-1β, TNFα, nitrate/nitrite and PGE2 levels in LPS-treated mice.

相关产品：Apoptosis Compound Library  |  Anti-Aging Compound Library  |  Antioxidants Compound Library  |  NF-κB Signaling Compound Library  |  Differentiation Inducing Compound Library  |  Oxygen Sensing Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  Anti-Cancer Compound Library  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Pyroptosis Compound Library  |  MG-132  |  LY294002  |  Actinomycin D  |  Mitomycin C  |  Doxorubicin hydrochloride  |  Bafilomycin A1  |  Paclitaxel  |  Y-27632 dihydrochloride  |  SP600125  |  Sorafenib  |  Angiotensin II human  |  MK-2206 dihydrochloride  |  5-Fluorouracil  |  Trametinib  |  Tamoxifen  |  Bortezomib  |  Gemcitabine  |  Pexidartinib  |  Acetylcysteine  |  Decitabine  |  BAY 11-7082  |  2-Deoxy-D-glucose  |  Docetaxel  |  Verteporfin  |  Temozolomide  |  Dasatinib  |  Ruxolitinib  |  Etoposide  |  DAPT

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。